Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis. (17th May 2018)

• Record Type: Journal Article
• Authors: Sinegre, T.; Duron, C.; Lecompte, T.; Pereira, B.; Massoulier, S.; Lamblin, G.; Abergel, A.; Lebreton, A.
• Is Part Of: Journal of thrombosis and haemostasis. Volume 16:Number 6(2018)
• Page Start: 1132
• Page End: 1140
• Publication Date: 2018-05-17
• Subjects: cirrhosis -- factor VIII -- hypercoagulability -- protein C -- thrombin generation; Thrombosis -- Periodicals; Hemostasis -- Periodicals; Blood coagulation disorders -- Periodicals; 616.1
• DOI: 10.1111/jth.14011
• Languages: English
• ISSNs: 1538-7933

Abstract

Summary: Essentials The role of increased factor VIII in cirrhosis‐induced hypercoagulability has never been demonstrated. Factor VIII and protein C effects were characterized by thrombin generation with thrombomodulin. Factor VIII elevation plays a significant role in cirrhosis‐induced plasma hypercoagulability. Only protein C and factor VIII normalization led to thrombin generation similar to controls. Summary: Background: In cirrhosis, thrombin generation (TG) studied in the presence of thrombomodulin (TM) indicates plasma hypercoagulability. Although the role of protein C (PC) deficiency has been investigated, the influence of an increase in the factor VIII level has never been addressed. Objectives: We investigated the roles of high FVIII and low PC levels in increased TG in the presence of TM. Methods: Blood samples were prospectively collected from 35 healthy controls and 93 patients with cirrhosis (Child–Turcotte–Pugh [CTP]‐A, n = 61; CTP‐B, n = 19; and CTP‐C, n = 13) and FVIII levels > 150% ( n = 48) and/or PC levels < 70% ( n = 88). TG was performed with tissue factor (5 pm ), phospholipids, and TM (4 nm ). FVIII and PC levels were normalized by adding an inhibitory anti‐FVIII antibody and exogenous PC, respectively. Results: The endogenous thrombin potential (ETP) in the presence of TM was higher in patients than in controls. After FVIII normalization, the ETP (median) decreased from 929 nm min to 621 nm min (CTP‐A), 1122 nm min to 1082 nm min (CTP‐B), and 1221 nm min to 1143 nm min (CTP‐C); after PC normalization, it decreased from 776 nm min to 566 nm min (CTP‐A), 1120 nm min to 790 nm min (CTP‐B), and 995 nm min to 790 nm min (CTP‐C). The ETP was reduced by 17% and 30%, respectively, but normal TG was not restored. When both FVIII and PC levels were normalized, the ETP decreased from 929 nm min to 340 nm min (CTP‐A), 1122 nm min to 506 nm min (CTP‐B), and 1226 nm min to 586 nm min (CTP‐C), becoming similar to control levels. Conclusion: Cirrhosis‐induced plasma hypercoagulability, as demonstrated in these experimental conditions, can be partly explained by opposite changes in two factors: PC level (decrease) and FVIII level (increase).